Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2009

View Archived Issues

Novel Janus kinase 2 inhibitors disclosed by Merck & Co.

AstraZeneca claims novel phthalazinone derivatives for cancer treatment

GSK reports novel glycine transporter inhibitors for schizophrenia treatment

Muscarinic M3 antagonists described by Pfizer for the treatment of COPD and asthma

Bayer claims novel compounds for the treatment of dyslipidemia

Biomarker identified for response to tipifarnib-bortezomib in acute myeloid leukemia

Saracatinib monotherapy shows little efficacy in advanced, castration-resistant prostate cancer

Novimmune designs antibodies with multiple specificities

Johnson & Johnson reviews first quarter 2009

Dainippon discontinues development of AC-3933 for dementia

Gilead begins phase II trial for integrase-based, single-tablet, once-daily HIV treatment

VentiRx initiates phase I VTX-1463 trial in allergic rhinitis

Galapagos and Merck to develop small-molecule drugs in inflammatory diseases

Preliminary results from ongoing phase I MDX-1401 trial in Hodgkin lymphoma patients reported

Multivalent, virosome-based breast cancer vaccine deemed safe, well tolerated in phase I trial

Pregabalin may be beneficial in patients with chronic hepatitis C

Advaxis initiates drug-licensing discussions in non-U.S. markets for ADXS11-001

PAION initiates phase Ib study of CNS-7056 in volunteers undergoing colonoscopy

Pharmacyclics and Servier enter global strategic alliance for PCI-24781

Adeona to acquire Colwell Clinical Laboratories

Amarillo supplies oral interferon for Australian human influenza study

Osiris completes enrollment in phase III Prochymal trial for graft vs. host disease

The European Commission withdraws marketing authorization for Velosulin

Gilead acquires CV Therapeutics

Factor VIIa inhibitors presented by Eisai for the treatment of thrombotic disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...